Clinical Trial Update: A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 bioequivalence study compared amodiaquine tablets from Pfizer with a marketed amodiaquine formulation (Arsuamoon) in healthy volunteers to assess p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Amodiaquine tablet (Arsuamoon - Guilin, China) (amodiaquine)
• Amodiaquine tablet (Pfizer) (amodiaquine)

Snippet

Sponsor: Pfizer | Conditions: Falciparum Malaria | Phase 1 | Status: COMPLETED